52 related articles for article (PubMed ID: 18356417)
1. Hypervascular thyroid nodules on time-resolved MR angiography at 3 T: radiologic-pathologic correlation.
Lohan DG; Tomasian A; Saleh R; Krishnam M; Finn JP
AJR Am J Roentgenol; 2008 Apr; 190(4):W255-60. PubMed ID: 18356417
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Nodules Detected by Contrast-Enhanced Magnetic Resonance Angiography: Prevalence and Clinical Significance.
Lim HK; Park ST; Ha H; Choi SY
PLoS One; 2016; 11(2):e0149811. PubMed ID: 26919607
[TBL] [Abstract][Full Text] [Related]
3. Thyroid incidentaloma detected by time-resolved magnetic resonance angiography at 3T: prevalence and clinical significance.
Choi N; Moon WJ; Kim HY; Roh HG; Choi JW
Korean J Radiol; 2012; 13(3):275-82. PubMed ID: 22563264
[TBL] [Abstract][Full Text] [Related]
4. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
Fink C; Bock M; Kiessling F; Lichy MP; Krissak R; Zuna I; Schmähl A; Delorme S; Kauczor HU
J Magn Reson Imaging; 2004 Feb; 19(2):202-8. PubMed ID: 14745754
[TBL] [Abstract][Full Text] [Related]
5. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
[TBL] [Abstract][Full Text] [Related]
6. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA.
Krishnam MS; Tomasian A; Lohan DG; Tran L; Finn JP; Ruehm SG
Clin Radiol; 2008 Jul; 63(7):744-55. PubMed ID: 18555032
[TBL] [Abstract][Full Text] [Related]
7. [Thyroid nodule. Study of 88 cases].
González Treviño O; Bolaños Gil F; Lerman Garber I; García-Rubí E; Maisterrena Fernández JA
Rev Invest Clin; 1993; 45(1):57-66. PubMed ID: 8484067
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of incidental thyroid nodules in patients with another primary malignancy.
Wilhelm SM; Robinson AV; Krishnamurthi SS; Reynolds HL
Surgery; 2007 Oct; 142(4):581-6; discussion 586-7. PubMed ID: 17950351
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-enhanced three-dimensional MR angiography of the aorta and peripheral arteries: evaluation of a multistation examination using two gadopentetate dimeglumine infusions.
Earls JP; Patel NH; Smith PA; DeSena S; Meissner MH
AJR Am J Roentgenol; 1998 Sep; 171(3):599-604. PubMed ID: 9725281
[TBL] [Abstract][Full Text] [Related]
10. Intraarterial versus IV gadolinium injections for MR angiography: quantitative and qualitative assessment of the infrainguinal arteries.
Schulte AC; Bongartz G; Huegli R; Aschwanden M; Jaeger KA; Ostheim-Dzerowycz W; Jacob AL; Bilecen D
AJR Am J Roentgenol; 2005 Sep; 185(3):735-40. PubMed ID: 16120927
[TBL] [Abstract][Full Text] [Related]
11. Distal lower extremity imaging: prospective comparison of 2-dimensional time of flight, 3-dimensional time-resolved contrast-enhanced magnetic resonance angiography, and 3-dimensional bolus chase contrast-enhanced magnetic resonance angiography.
Hahn WY; Hecht EM; Friedman B; Babb JS; Jacobowitz GR; Lee VS
J Comput Assist Tomogr; 2007; 31(1):29-36. PubMed ID: 17259830
[TBL] [Abstract][Full Text] [Related]
12. [The thyroid nodule. Diagnostic considerations].
Danese D; Sciacchitano S
Minerva Endocrinol; 1993 Sep; 18(3):129-37. PubMed ID: 8183180
[TBL] [Abstract][Full Text] [Related]
13. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
[TBL] [Abstract][Full Text] [Related]
15. The role of time-resolved 3D contrast-enhanced MR angiography in the assessment and grading of cerebral arteriovenous malformations.
Oleaga L; Dalal SS; Weigele JB; Hurst RW; Lee J; Voorhees A; Melhem ER
Eur J Radiol; 2010 Jun; 74(3):e117-21. PubMed ID: 19467814
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR angiography of the breast: Evaluation of ipsilateral increased vascularity and adjacent vessel sign in the characterization of breast lesions.
Kul S; Cansu A; Alhan E; Dinc H; Reis A; Çan G
AJR Am J Roentgenol; 2010 Nov; 195(5):1250-4. PubMed ID: 20966336
[TBL] [Abstract][Full Text] [Related]
17. Is half-dose contrast-enhanced three-dimensional MR angiography sufficient for the abdominal aorta and pelvis?
Takahashi S; Murakami T; Takamura M; Kim T; Hori M; Narumi Y; Nakamura H
J Magn Reson Imaging; 2004 Feb; 19(2):194-201. PubMed ID: 14745753
[TBL] [Abstract][Full Text] [Related]
18. Thyroid nodules and the detection of thyroid cancer.
Haber RS
Mt Sinai J Med; 1996 Jan; 63(1):10-5. PubMed ID: 8935844
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of malignancy within cytologically indeterminate thyroid nodules.
Miller B; Burkey S; Lindberg G; Snyder WH; Nwariaku FE
Am J Surg; 2004 Nov; 188(5):459-62. PubMed ID: 15546550
[TBL] [Abstract][Full Text] [Related]
20. Decreased venous contamination on 3D gadolinium-enhanced bolus chase peripheral mr angiography using thigh compression.
Zhang HL; Ho BY; Chao M; Kent KC; Bush HL; Faries PL; Benvenisty AI; Prince MR
AJR Am J Roentgenol; 2004 Oct; 183(4):1041-7. PubMed ID: 15385302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
